Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

Dominik Dytfeld, Jagoda Jasielec, Kent A. Griffith, Daniel Lebovic, David H. Vesole, Sundar Jagannath, Ammar Al-Zoubi, Tara Anderson, Kristen Detweiler-Short, Keith Stockerl-Goldstein, Asra Ahmed, Terri Jobkar, Diane E. Durecki, Kathryn McDonnell, Melissa Mietzel, Daniel Couriel, Mark Kaminski, Ravi Vij, Andrzej J. Jakubowiak

Research output: Contribution to journalLetterpeer-review

38 Scopus citations
Original languageEnglish
Pages (from-to)e162-e164
JournalHaematologica
Volume99
Issue number9
DOIs
StatePublished - Sep 1 2014

Keywords

  • Carfilzomib
  • Elderly
  • Lenalidomide
  • Low-dose dexamethasone
  • Multiple myeloma
  • Newly diagnosed

Cite this